China Resourcesnjiu Medical & Pharmaceutical Co (SZSE:000999) Cash-to-Debt : 2.95 (As of Mar. 2024)

View and export this data going back to 2000. Start your Free Trial

What is China Resourcesnjiu Medical & Pharmaceutical Co Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. China Resourcesnjiu Medical & Pharmaceutical Co's cash to debt ratio for the quarter that ended in Mar. 2024 was 2.95.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, China Resourcesnjiu Medical & Pharmaceutical Co could pay off its debt using the cash in hand for the quarter that ended in Mar. 2024.

The historical rank and industry rank for China Resourcesnjiu Medical & Pharmaceutical Co's Cash-to-Debt or its related term are showing as below:

SZSE:000999' s Cash-to-Debt Range Over the Past 10 Years
Min: 1.24 Med: 3.4 Max: 105.55
Current: 2.95

During the past 13 years, China Resourcesnjiu Medical & Pharmaceutical Co's highest Cash to Debt Ratio was 105.55. The lowest was 1.24. And the median was 3.40.

SZSE:000999's Cash-to-Debt is ranked better than
65.71% of 1047 companies
in the Drug Manufacturers industry
Industry Median: 0.95 vs SZSE:000999: 2.95

China Resourcesnjiu Medical & Pharmaceutical Co Cash-to-Debt Historical Data

The historical data trend for China Resourcesnjiu Medical & Pharmaceutical Co's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

China Resourcesnjiu Medical & Pharmaceutical Co Cash-to-Debt Chart

China Resourcesnjiu Medical & Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash-to-Debt

Get a 7-Day Free Trial

103.05

22.47

17.99

8.05

2.76

China Resourcesnjiu Medical & Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Cash-to-Debt	Get a 7-Day Free Trial															2.83	1.98	2.50	2.76	2.95

Competitive Comparison of China Resourcesnjiu Medical & Pharmaceutical Co's Cash-to-Debt

For the Drug Manufacturers - Specialty & Generic subindustry, China Resourcesnjiu Medical & Pharmaceutical Co's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

China Resourcesnjiu Medical & Pharmaceutical Co's Cash-to-Debt Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, China Resourcesnjiu Medical & Pharmaceutical Co's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where China Resourcesnjiu Medical & Pharmaceutical Co's Cash-to-Debt falls into.

China Resourcesnjiu Medical & Pharmaceutical Co Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

China Resourcesnjiu Medical & Pharmaceutical Co's Cash to Debt Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	8226.787	/	(1063.723	+	1922.443)
	=	2.75

China Resourcesnjiu Medical & Pharmaceutical Co's Cash to Debt Ratio for the quarter that ended in Mar. 2024 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	8829.901	/	(1098.298	+	1892.627)
	=	2.95

China Resourcesnjiu Medical & Pharmaceutical Co (SZSE:000999) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

China Resourcesnjiu Medical & Pharmaceutical Co Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of China Resourcesnjiu Medical & Pharmaceutical Co's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

China Resourcesnjiu Medical & Pharmaceutical Co (SZSE:000999) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » China Resources Sanjiu Medical & Pharmaceutical Co Ltd (SZSE:000999) » Definitions » Cash-to-Debt

Traded in Other Exchanges

N/A

Address

High-Tech Park, Lake Street Mission Hills, Longhua District, Shenzhen, CHN, 518110

Website

http://www.999.com.cn

China Resources Sanjiu Medical & Pharmaceutical Co Ltd is a China-based pharmaceutical company. It is engaged in the research and development, production and sale of pharmaceutical products, healthcare products, and medical appliances under the brand name 999, which includes OTC, antibiotic and raw material drug. The other brands under which the company offers its products are Lee King, Shunfeng, and Tianhe. The company's core business is located in OTC and Chinese medicine prescription drugs, OTC core products in the cold, gastrointestinal, skin, pediatric, cough and orthopedic drugs occupy a higher market share; prescription drug products in traditional Chinese medicine formula granules, cardiovascular and cerebrovascular, anti-tumor in the field of anti-infection and other areas.

China Resourcesnjiu Medical & Pharmaceutical Co (SZSE:000999) Headlines

No Headlines